Sign in / Join Now
ETFs & Funds
Life Sciences Report
Fire Up The Immuno-Oncology Powerhouses: John McCamant $
Add a reply...
Latest StockTalks »
people get ANTH breaking news and analysis by email alert.
Get email alerts on ANTH »
Anthera Pharmaceuticals, Inc.
Get latest price
From other sites
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of Anthera Pharmaceuticals, Inc.
at TheStreet (Fri, 1:49PM)
Anthera Announces The Phase 3 SOLUTION Study With Sollpura™ In Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency Demonstrates Encouraging Results - Additional Study Needed
at TheStreet (Dec 27, 2016)
Are Options Traders Betting on a Big Move in Anthera Pharmaceuticals (ANTH) Stock?
at Zacks.com (Dec 27, 2016)
Anthera Pharmaceuticals Announces Continuation Of SIMPLICITY Study Of Sollpura™ Following Positive DMC Review
at TheStreet (Dec 13, 2016)
Anthera Announces Leadership Transition In Preparation Of Commercialization Of Sollpura And Future Development Of Blisibimod For IgA Nephropathy
at TheStreet (Dec 6, 2016)